Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

U.S. Flag An official website of the United States government.
Change Font Size

States' Collection of Medicaid Rebates from Drug Manufacturers

In this series of reports, OIG is determining whether each State billed and collected from pharmaceutical manufacturers the rebates they owe to States and Federal Government for outpatient drugs dispensed in the Medicaid program.

Most of the reports in this series of reports focus on traditional Medicaid (fee-for-service), looking at rebates for drugs administered by physicians in an office or hospital outpatient facility. Other reports focus on Medicaid managed care, some looking at just drugs administered by physicians and some looking at rebates for all outpatient drugs.

View this series in a text-based table.

Arkansas Arizona California Colorado Washington, DC Delaware Delaware Hawaii Idaho Iowa Kansas Louisana Maryland Maryland Montana Missouri Nebraska Nevada North Dakota Ohio Oklahoma Oregon South Dakota Texas Utah Virginia Washington Wisconsin Wyoming

Last Updated February 21, 2018

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201